OMDAOmada Health, Inc.

Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are covering the company, MarketBeat.com...

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,541,079 shares, an increase of 24.5% from the March 15th total of 2,843,612 shares. Based on an average daily...

Citizens Jmp began coverage on Omada Health in a research note on Tuesday. They set a "market outperform" rating and a $18.00 target price for the company...

Liberty Street Advisors Inc. lowered its position in Omada Health, Inc. (NASDAQ:OMDA - Free Report) by 50.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,800 shares of the com...

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) was the target of some unusual options trading on Monday. Stock investors purchased 3,067 call options on the stock. This represents an increase of 503% compared to the average volume of 509 call options...

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) President Wei-Li Shao sold 2,829 shares of the firm's stock in a transaction on Wednesday, April 8th. The stock was sold at an average price of...

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) President Wei-Li Shao sold 2,829 shares of the stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $12.71...

Omada Health (NASDAQ:OMDA) Shares Down 6.6% Following Analyst Downgrade...